Cart
sales@molnova.com
BRM/BRG1 ATP Inhibitor-2
CAS No. 2368900-77-8
BRM/BRG1 ATP Inhibitor-2( —— )
Catalog No. M28502 CAS No. 2368900-77-8
BRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 147 | In Stock |
|
| 5MG | 132 | In Stock |
|
| 10MG | 211 | In Stock |
|
| 25MG | 425 | In Stock |
|
| 50MG | 613 | In Stock |
|
| 100MG | 873 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1748 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBRM/BRG1 ATP Inhibitor-2
-
NoteResearch use only, not for human use.
-
Brief DescriptionBRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
-
DescriptionBRM/BRG1 ATP Inhibitor-2 is an inhibitor of BRG1/BRM ATPase and can be used in studies about the treatment of BAF-related disorders.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetEpigenetic Reader Domain
-
Recptor——
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2368900-77-8
-
Formula Weight412.53
-
Molecular FormulaC20H20N4O2S2
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (242.41 mM)
-
SMILESCSCC[C@H](NC(C1=CN=CC=C1)=O)C(NC2=NC(C3=CC=CC=C3)=CS2)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
dBRD9 HCl
dBRD9 HCl is a PROTAC composed of the BRD9 inhibitor BI 7273 conjugated to the cereblon E3 ligase ligand pomalidomide . dBRD9 HCl is a potent and selective degrader of BRD9 (IC50 = 56.6 nM in MOLM-13 cells).
-
GSK046
GSK046 is a potent, selective and orally active BD2 bromodomain inhibitor of the BET proteins(IC50s of 264 nM (BRD2 BD2), 98 nM (BRD3 BD2), 49 nM (BRD4 BD2) and 214 nM (BRDT BD2), respectively).
-
SRX3177
SRX3177 is a novel and potent inhibitor of BRD4, PI3K and CDK.SRX3177 has potential anticancer activity.
